Close

Immunovant, Inc. (IMVT) Misses Q2 EPS by 4c

November 4, 2022 7:05 AM EDT

Immunovant, Inc. (NASDAQ: IMVT) reported Q2 EPS of ($0.41), $0.04 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings